Parkinson's paradox: alpha-synuclein's selective strike on SNc dopamine neurons over VTA
- PMID: 40646031
- PMCID: PMC12254511
- DOI: 10.1038/s41531-025-01055-3
Parkinson's paradox: alpha-synuclein's selective strike on SNc dopamine neurons over VTA
Abstract
A central question in Parkinson's disease (PD) and related synucleinopathies research is why dopamine neurons in the substantia nigra pars compacta (SNc) are more vulnerable than those in the ventral tegmental area (VTA). We investigated how α-synuclein affects neuronal activity before cell death using two mouse models: α-synuclein preformed fibril injections and AAV-mediated human α-synuclein expression. Four-weeks post-injection, histological analysis confirmed no significant neuronal loss in either structure, providing a temporal window to study neuronal activity before cell death. Electrophysiological recordings revealed region-specific vulnerability: SNc dopamine neurons exhibited significantly increased baseline firing rates while VTA neurons remained unaffected. SNc neurons showed impaired homeostatic firing regulation following hyperpolarization, while VTA neurons maintained normal recovery. Elevated α-synuclein also altered network stability in SNc dopamine neurons before cell death, while sparing VTA neurons. These findings reveal early functional differences that may explain the selective vulnerability of SNc dopamine neurons in PD.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures








Update of
-
Parkinson's Paradox: Alpha-synuclein's Selective Strike on SNc Dopamine Neurons over VTA.bioRxiv [Preprint]. 2025 Apr 2:2025.03.24.644952. doi: 10.1101/2025.03.24.644952. bioRxiv. 2025. Update in: NPJ Parkinsons Dis. 2025 Jul 11;11(1):207. doi: 10.1038/s41531-025-01055-3. PMID: 40236072 Free PMC article. Updated. Preprint.
Similar articles
-
Parkinson's Paradox: Alpha-synuclein's Selective Strike on SNc Dopamine Neurons over VTA.bioRxiv [Preprint]. 2025 Apr 2:2025.03.24.644952. doi: 10.1101/2025.03.24.644952. bioRxiv. 2025. Update in: NPJ Parkinsons Dis. 2025 Jul 11;11(1):207. doi: 10.1038/s41531-025-01055-3. PMID: 40236072 Free PMC article. Updated. Preprint.
-
Transient receptor potential vanilloid 2 (TRPV2) channels modulate the nigrostriatal dopaminergic activity in rats.Neuropharmacology. 2025 Nov 1;278:110545. doi: 10.1016/j.neuropharm.2025.110545. Epub 2025 Jun 3. Neuropharmacology. 2025. PMID: 40473103
-
Leptin activates dopamine and GABA neurons in the substantia nigra via a local pars compacta-pars reticulata circuit.J Neurosci. 2025 Mar 24;45(21):e1539242025. doi: 10.1523/JNEUROSCI.1539-24.2025. Online ahead of print. J Neurosci. 2025. PMID: 40127936
-
Three paradoxes related to the mode of action of pramipexole: The path from D2/D3 dopamine receptor stimulation to modification of dopamine-modulated functions.J Psychopharmacol. 2024 Jul;38(7):581-596. doi: 10.1177/02698811241261022. Epub 2024 Jul 23. J Psychopharmacol. 2024. PMID: 39041250 Review.
-
SynNeurGe: The road ahead for a biological definition of Parkinson's disease.J Parkinsons Dis. 2025 Aug;15(5):931-938. doi: 10.1177/1877718X241298194. Epub 2024 Dec 8. J Parkinsons Dis. 2025. PMID: 39973492 Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous